Evolocumab (subcutaneous route) side effects
Evolocumab is a PCSK9 inhibitor marketed under the name Repatha, which is prescribed to lower cholesterol levels and reduce cardiovascular risks. While Evolocumab can be an effective treatment for many patients, understanding the potential side effects and managing them appropriately is crucial. This article will explore the common side effects of Evolocumab and provide guidance … Read more